Table 3. Subgroup analysis of the associations between 30-day mortality and the LAR level.
| Subgroup | Total | LAR | P for interaction | ||
|---|---|---|---|---|---|
| <8.7 | 8.7–30.9 | >30.9 | |||
| Age (years) | 0.223 | ||||
| <60 | 152 | 1 | 1.76 (1.03, 3.00) | 3.33 (1.93, 5.77) | |
| ≥60 | 206 | 1 | 2.08 (1.34, 3.24) | 2.55 (1.50, 4.32) | |
| Sex | 0.009 | ||||
| Male | 221 | 1 | 1.56 (1.03, 2.36) | 2.74 (1.75, 4.30) | |
| Female | 137 | 1 | 3.01 (1.64, 5.51) | 3.93 (2.02, 7.67) | |
| Myocardial infarction | 0.268 | ||||
| No | 290 | 1 | 1.78 (1.24, 2.55) | 3.13 (2.09, 4.67) | |
| Yes | 68 | 1 | 4.43 (1.34, 14.65) | 5.16 (1.51, 17.61) | |
| Cerebrovascular disease | 0.237 | ||||
| No | 286 | 1 | 2.17 (1.45, 3.26) | 3.89 (2.51, 6.03) | |
| Yes | 72 | 1 | 1.60 (0.84, 3.04) | 1.47 (0.69, 3.13) | |
| Chronic lung disease | 0.728 | ||||
| No | 277 | 1 | 1.89 (1.29, 2.78) | 3.57 (2.36, 5.42) | |
| Yes | 81 | 1 | 2.34 (1.12, 4.90) | 1.80 (0.76, 4.29) | |
| Liver disease | 0.002 | ||||
| No | 237 | 1 | 1.96 (1.34, 2.88) | 2.74 (1.75, 4.30) | |
| Yes | 121 | 1 | 2.20 (0.99, 4.87) | 4.22 (1.87, 9.51) | |
| Diabetes | 0.139 | ||||
| No | 276 | 1 | 2.09 (1.38, 3.15) | 3.26 (2.10, 5.07) | |
| Yes | 82 | 1 | 1.74 (0.94, 3.22) | 2.79 (1.29, 6.00) | |
| Renal disease | 0.719 | ||||
| No | 314 | 1 | 2.11 (1.45, 3.08) | 3.27 (2.18, 4.91) | |
| Yes | 44 | 1 | 1.28 (0.56, 2.89) | 2.31 (0.81, 6.60) | |
| Malignancy | 0.520 | ||||
| No | 283 | 1 | 1.80 (1.25, 2.60) | 2.97 (1.98, 4.44) | |
| Yes | 75 | 1 | 3.23 (1.24, 8.40) | 4.46 (1.61, 12.32) | |
LAR, lactic dehydrogenase-to-albumin ratio.